
IDBI Capital maintained its constructive stance on four stocks across power equipment, specialty chemicals and industrial capital goods sectors following their Q2FY27 performance reviews. According to reports from NDTV Profit, the brokerage reiterated Buy ratings on Navin Fluorine, Ador Welding, Acutaas and GE Vernova after reviewing their quarterly results. The brokerage cited strong earnings visibility, healthy order pipelines and robust sectoral demand trends as key drivers for its positive outlook across these sectors.
In the power transmission and equipment space, GE Vernova T&D India reported 32% YoY revenue growth and 44% growth in profit after tax during the quarter, supported by strong execution and order inflows. As reported by NDTV Profit, IDBI Capital maintained its Buy rating and target price of ₹5,214, implying a potential upside of about 30% from current levels. The brokerage highlighted the company's ₹21,440-crore order backlog, healthy HVDC opportunity pipeline and expanding localisation capabilities as key growth levers.
Navin Fluorine International delivered a strong quarter with revenue, EBITDA and PAT rising 57%, 66% and 82% YoY, respectively. According to NDTV Profit, IDBI Capital retained its Buy rating and assigned a revised target price of ₹10,001, implying about 15% upside. The brokerage remains optimistic on growth across high-performance products, specialty chemicals and CDMO businesses, supported by capacity expansions and a robust product pipeline. The company's H1 FY27 operating revenue rose 51% to ₹2,236 crore, with EBITDA increasing 69% to ₹765 crore and PAT climbing 93% to ₹513 crore.
Ador Welding posted 23% revenue growth in Q2 FY27, aided by higher volumes and better realisations, though margins remained under pressure due to inflation in raw material prices. As reported by NDTV Profit, IDBI Capital maintained its Buy rating and revised target price of ₹1,771, indicating a potential upside of around 33%. The brokerage expects Ador to benefit from rising demand from infrastructure, oil and gas, shipbuilding, defence and automation-related opportunities.
Acutaas registered robust financials in Q2 FY27 propelled by continued strong growth in the CDMO and Non-CDMO Business. According to NDTV Profit, revenue, EBITDA and PAT grew by 43%, 85% and 73% respectively on YoY basis. IDBI Capital has maintained a 'Buy' rating on the chemical stock with a revised target price of ₹4,851 at 50 times FY28 expected earnings, implying a potential upside of 21% from the report's market price.